|
|
Volumn 5, Issue 5 SPEC.ISS., 2005, Pages 449-451
|
|
Anti-infectives: Resistance, biothreats and prospects for new agents
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMOXICILLIN PLUS CLAVULANIC ACID;
ANTIBIOTIC AGENT;
ANTIINFECTIVE AGENT;
ANTIMALARIAL AGENT;
BACTERIAL ENZYME;
BETA LACTAM ANTIBIOTIC;
BETA LACTAMASE;
CARBAPENEM;
CEPHALOSPORIN;
LEUKOCIDIN;
METICILLIN;
POLYPEPTIDE ANTIBIOTIC AGENT;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
VANCOMYCIN;
ANTIBIOTIC RESISTANCE;
BACTERIAL GENE;
BACTERIAL INFECTION;
BACTERIAL STRAIN;
BIOLOGICAL WARFARE;
CLINICAL PRACTICE;
COMMUNICABLE DISEASE;
DRUG EFFICACY;
DRUG RESEARCH;
DRUG TARGETING;
EDITORIAL;
FINANCIAL MANAGEMENT;
GENE SEQUENCE;
GRAM NEGATIVE BACTERIUM;
GRAM NEGATIVE INFECTION;
HUMAN;
INFECTION CONTROL;
MALARIA;
MEDICAL DECISION MAKING;
MEDICAL RESEARCH;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
PLASMODIUM MALARIAE;
PREDICTION;
PRIORITY JOURNAL;
PROTOZOAL INFECTION;
STAPHYLOCOCCUS AUREUS;
STREPTOCOCCUS PNEUMONIAE;
THREAT;
|
|
EID: 24344505864
PISSN: 14714892
EISSN: None
Source Type: Journal
DOI: 10.1016/j.coph.2005.07.003 Document Type: Editorial |
|
Times cited : (1)
|
|
References (0)
|
